Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men - Wikidata - awgldk - TriplyDB

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

http://www.wikidata.org/entity/Q34560789

about

Dyslipidaemia of diabetes and the intestine Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.The chylomicron: relationship to atherosclerosis.Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.The effects of jiang-zhi-ning and its main components on cholesterol metabolism.Visualization of lipid metabolism in the zebrafish intestine reveals a relationship between NPC1L1-mediated cholesterol uptake and dietary fatty acid.Does rosuvastatin increase serum levels of 25-hydroxy-vitamin D?Glucagon receptor antagonism induces increased cholesterol absorption.Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes.Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemia.Potential of proprotein convertase subtilisin/kexin type 9 based therapeutics.Plant polyisoprenoids and control of cholesterol level.Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials.Overactivation of intestinal Sterol Response Element Binding Protein 2 promotes diet-induced non-alcoholic steatohepatitis.Lipid Lowering Therapy and Circulating PCSK9 Concentration.Transporters for the Intestinal Absorption of Cholesterol, Vitamin E, and Vitamin K.Emerging pathways in the regulation of whole body cholesterol flux: therapeutic opportunities to target atherosclerosis?PCSK9 in chronic kidney disease.Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment.Location, location, location...again.Overactivation of intestinal SREBP2 in mice increases serum cholesterol.Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.Lipid Uptake, Metabolism, and Transport in the Larval Zebrafish.Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.Molecular Pathways Underlying Cholesterol Homeostasis.Erchen Decoction Ameliorates Lipid Metabolism by the Regulation of the Protein CAV-1 and the Receptors VLDLR, LDLR, ABCA1, and SRB1 in a High-Fat Diet Rat Model

P2860

Q26799589-AACF6EA0-E84A-4BC8-9360-FCE3C8860AB3 Q27003094-7442696E-3E46-4CB8-BCA9-0D01DAD28DB4 Q35077618-EF0DC0CA-18D8-4557-ABEF-FF40F2E7C05D Q35295065-3D24557F-F602-4386-A0CA-5E7FDBF599E1 Q35958491-AA8092BE-E4DC-4EF1-984C-21FB50DD0D1B Q35977838-DF79FD9D-4AD3-4627-89A2-DC4F527E7EA4 Q36129524-FE0D37FC-F52C-47FC-B6E5-11D8DC77FBA1 Q36130004-972CC40C-D576-4744-9C77-B0DDF6AFD3B7 Q36197864-6F7BA722-EA9B-4B19-B7ED-693E04A8447B Q37033222-4CFF55F7-727C-4C53-BBB1-11A76E2BCD68 Q37392958-34C8FCEF-3007-4DAD-8E2F-239D87819086 Q37590276-F0D44EEB-8919-4F5C-8A03-F99B1BF1CA2B Q37707904-0C96BB94-D0BD-43E6-A7D9-0BC96E9801B3 Q38001736-46256109-ACF1-44D9-AFFE-ED82B9387ED7 Q38078264-0E6FB967-3217-43ED-83C9-B5B9AF80C974 Q38133372-98718F3B-2338-489D-AF56-56E972D42398 Q38548750-9D844E7B-3225-4ADB-9B35-398740B2B139 Q38642491-E71EE18A-612E-4EF9-9A3E-5EF741D9805A Q38643197-4D9691BF-28FD-46FD-A749-DAE162EDD99C Q38768787-4A136808-4EE4-4A99-BD39-A0454E23A282 Q38892210-0C8B7705-E59F-4280-9F6C-4078F194DD02 Q39022581-D5CAF570-BCAC-4996-8457-00DB25F504DF Q40573729-B903EDAC-DC70-4F4F-B2F9-953F595B30E2 Q41830674-9567C661-9770-4633-A7B1-12231BD71AC0 Q41880154-D9AC956A-4E3E-4C24-A95E-E0E47506A819 Q46767535-DA670364-6A49-49AE-A59A-D853B4BC6AFB Q47165156-2D947649-EA2D-4367-A78E-A1A9D8DBC4A9 Q48830924-163C4ED8-BB58-4092-84B4-DB979C6AE649 Q51615169-ADD8D55D-3B91-4A86-AB48-163B1DCB8CD0 Q55515157-2F7B84A4-896C-4DA9-8DB7-D17EEB4F11F5 Q58580354-F4BE6414-36D8-4D83-90D8-359242B6E768

P2860

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

http://www.wikidata.org/entity/Q34560789

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@ast

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@en

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@nl

type

label

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@ast

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@en

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@nl

prefLabel

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@ast

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@en

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@nl

P1433

Q34560789-979DAC08-CBDC-479D-AEDF-C01A05891761

P1476

Q34560789-DAD4EB7E-C550-4B50-8366-D03842F13562

P2093

Q34560789-2234E05B-672F-4E4F-8412-75A240F22AAD

Q34560789-58059518-9723-4BBC-BACE-2678A410BDB1

Q34560789-6CBFA7FA-7EA1-4409-86D8-707DC842E26E

Q34560789-7582E3FF-7833-4DEB-8F74-919F5E4C0AE4

Q34560789-C5D08506-4CE1-4E5D-8350-66BB2B770007

Q34560789-D74F3D30-99FE-4EBE-B975-464CD4A783B7

Q34560789-FDDBFDB7-7B43-4787-AC86-95BF37E4977E

P2860

Q34560789-0027FF7C-8752-452B-8B21-E61AAE13CCE0

Q34560789-030B045A-64E3-4275-B463-E91E641E8442

Q34560789-07455989-FC5A-45E3-BC78-912EF790A5B7

Q34560789-0A7F52BD-097C-465F-8112-BBD64E0BE0F3

Q34560789-0EFE6FC8-27FC-4BBF-9D81-686D046A74DB

Q34560789-16EABB2D-8673-43B2-860E-B93C45A977DD

Q34560789-2442A1A4-628A-4E8F-9800-E8EE7864601C

Q34560789-29765357-97A6-43D5-BDFA-7091B4A7383D

Q34560789-29C0A3EB-286E-4BEA-8AC9-E36DD5465FAD

Q34560789-2E3F08DC-C14D-4395-8DFF-0F8354BDD8B2

P304

Q34560789-E09F560A-28BD-44BF-ACDF-BF7C4A7941D0

P31

Q34560789-78E586A5-1EE1-447D-8F37-E19BE0DC2C04

P356

Q34560789-51103FCB-61C2-44BF-B276-367073A73E09

P433

Q34560789-011238BC-3E17-4DAD-A00C-A2856F2FAAAB

P478

Q34560789-0EE0C627-1B4D-4509-B7D7-C4C80790741D

P50

Q34560789-A4AA3A94-FD3B-48AA-9DAA-91D73D3535CB

P577

Q34560789-27A758F2-AB3F-4E98-A8DE-3E5929672376

P698

Q34560789-59F3B143-71C4-46D2-9E6F-EA1D3D8E05BB

P921

Q34560789-BD075768-25C2-48F1-ABC5-B77E4D5FCA0F

P932

Q34560789-363C28AD-135F-48D0-A552-10DE52EEF13F

P356

P1433

Journal of Lipid Research

P1476

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

@en

P2093

André J Tremblay

http://www.w3.org/2001/XMLSchema#string

Benoît Lamarche

http://www.w3.org/2001/XMLSchema#string

Harry R Davis

http://www.w3.org/2001/XMLSchema#string

Lizbeth Hoos

http://www.w3.org/2001/XMLSchema#string

Patrick Couture

http://www.w3.org/2001/XMLSchema#string

Suzanne Benjannet

http://www.w3.org/2001/XMLSchema#string

Valéry Lemelin

http://www.w3.org/2001/XMLSchema#string

P2860

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion

The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

Sterol regulatory element-binding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein

Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women

Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

P304

558-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M011080

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21123766

http://www.w3.org/2001/XMLSchema#string

P921

P932

3035692

http://www.w3.org/2001/XMLSchema#string